Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

NCT03977090 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Geptanolimab Injection
DRUG: Fruquintinib

Sponsor

Genor Biopharma Co., Ltd.

Collaborators

[object Object]